Neonatology probably has more international networks than any other subspecialty group in pediatrics, networks responsible for conducting large randomized control trials, educating staff, and leading quality improvement studies. The good news is that, thanks to these networks, we are making progress in improving infant mortality and morbidity. The not so good news is that such improvements take more time than they potentially should, resulting in suboptimal outcomes for infants who are deprived of newer therapies with yet untested potential benefit.

From a good news standpoint, infant mortality rates have decreased during this decade as evidenced by articles such as that by Horbar et al1 in the current issue of Pediatrics. This article shows data on 355 806 infants weighing between 501 and 1500 g at birth, born between 2000 and 2009 in the Vermont-Oxford Network, and indicates that significant progress is being made. On the other hand, 49%...

You do not currently have access to this content.